FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

LN Klapper

Research Profile

Chemicals & Drugs

Physiology

Living Beings

Anatomy

Phenomena

Co-author Network

Publications

TOP 3
Nora Vaisman; A Nissim; LN Klapper; Boaz Tirosh; Yosef Yarden; Michael Sela
Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library.
Gil Levkowitz; Shlomo Oved; LN Klapper; Daniel Harari; Sara Lavi; Michael Sela; Yosef Yarden
c-Cbl is a suppressor of the neu oncogene.
E Hurwitz; LN Klapper; M Wilchek; Yosef Yarden; Michael Sela
Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of LN Klapper (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Nora Vaisman; A Nissim; LN Klapper; Boaz Tirosh; Yosef Yarden; Michael Sela
Specific inhibition of the reaction between a tumor-inhibitory antibody and the ErbB-2 receptor by a mimotope derived from a phage display library.
Immunology letters 2000;75(1):61-7.
2000: Gil Levkowitz; Shlomo Oved; LN Klapper; Daniel Harari; Sara Lavi; Michael Sela; Yosef Yarden
c-Cbl is a suppressor of the neu oncogene.
The Journal of biological chemistry 2000;275(45):35532-9.
2000: E Hurwitz; LN Klapper; M Wilchek; Yosef Yarden; Michael Sela
Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies.
Cancer immunology, immunotherapy : CII 2000;49(4-5):226-34.
2000: LN Klapper; Hadassa Waterman; Michael Sela; Yosef Yarden
Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.
Cancer research 2000;60(13):3384-8.
2000: LN Klapper; M H Kirschbaum; Michael Sela; Yosef Yarden
Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.
Advances in cancer research 2000;77():25-79.
1999: LN Klapper; S Glathe; Nora Vaisman; N E Hynes; glenn andrews; Michael Sela; Yosef Yarden
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(9):4995-5000.
1998: Lenferink Anne; Ronit Pinkas-Kramarski; Monique L M van De Poll; MJ van Vugt; LN Klapper; E Tzahar; Hadassa Waterman; Michael Sela; Everardus J J van Zoelen; Yosef Yarden
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.
The EMBO journal 1998;17(12):3385-97.
1998: Ronit Pinkas-Kramarski; Lenferink Anne; Sarah S Bacus; Ljuba Lyass; Monique L M van De Poll; LN Klapper; E Tzahar; Michael Sela; Everardus J J van Zoelen; Yosef Yarden
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Oncogene 1998;16(10):1249-58.
1997: E Tzahar; Ronit Pinkas-Kramarski; JD Moyer; LN Klapper; Iris Alroy; Gil Levkowitz; Maya Shelly; S Henis; Miriam Eisenstein; BJ Ratzkin; Michael Sela; glenn andrews; Yosef Yarden
Bivalence of EGF-like ligands drives the ErbB signaling network.
The EMBO journal 1997;16(16):4938-50.
1997: LN Klapper; Nora Vaisman; E Hurwitz; Ronit Pinkas-Kramarski; Yosef Yarden; Michael Sela
A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors.
Oncogene 1997;14(17):2099-109.
1996: Ronit Pinkas-Kramarski; L Soussan; Hadassa Waterman; Gil Levkowitz; Iris Alroy; LN Klapper; S Lavi; Rony Seger; B J Ratzkin; Michael Sela; Yosef Yarden
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
The EMBO journal 1996;15(10):2452-67.
1996: Gil Levkowitz; LN Klapper; E Tzahar; A Freywald; Michael Sela; Yosef Yarden
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.
Oncogene 1996;12(5):1117-25.